<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Cetirizine - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Cetirizine</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../index.html">Home</a>
        <a class="btn small" href="../medications.html">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Respiratory / Allergy</div>
      <h1>Cetirizine</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Cetirizine 10mg Tablets</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <ul>
          <li><strong>Allergic rhinitis (seasonal/perennial)</strong>
            <ul>
              <li>10 mg PO once daily as needed</li>
            </ul>
          </li>
          <li><strong>Urticaria (hives) / pruritus from allergic triggers</strong>
            <ul>
              <li>10 mg PO once daily</li>
            </ul>
          </li>
          <li><strong>If sensitive to sedation</strong>
            <ul>
              <li>Consider 5 mg PO once daily (half-tablet) if feasible/appropriate; reassess</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Symptomatic relief of allergic rhinitis (sneezing, rhinorrhea, itchy/watery eyes)</li>
          <li>Symptomatic relief of urticaria and itch related to allergic triggers</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>Hypersensitivity to cetirizine, hydroxyzine, or piperazine derivatives</li>
          <li>Sedation can occur (less than first-generation antihistamines but still possible): caution with watchkeeping, machinery, and alcohol/sedatives</li>
          <li>Renal impairment: dose reduction may be required (follow product monograph/local guidance)</li>
          <li>Caution in older adults if fall risk or concurrent sedatives</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>Drowsiness/fatigue, dizziness</li>
          <li>Dry mouth</li>
          <li>Headache</li>
          <li>GI upset (uncommon)</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>PO tablet; may take with or without food</li>
          <li>If drowsy, consider taking in the evening (operationally) and reassess daytime performance</li>
          <li>Avoid combining with other sedating meds/alcohol when possible</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Symptom control (rhinitis/urticaria)</li>
          <li>Sedation/functional impairment (especially first dose and when combined with other CNS depressants)</li>
          <li>If prolonged use in renal impairment: monitor for increased sedation and reassess need/dose</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>Operational safety: warn about drowsiness; consider first dose at a time when the member is not on critical duties</li>
          <li>If symptoms are primarily nasal congestion, ensure non-sedating options and local pathways are also considered (e.g., nasal steroid use if stocked and appropriate)</li>
          <li>Document response and any sedation to guide future selection (cetirizine vs loratadine, etc.)</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Health Canada product monograph (cetirizine / Reactine reference product): <a href="https://pdf.hres.ca/dpd_pm/00040767.PDF" target="_blank">https://pdf.hres.ca/dpd_pm/00040767.PDF</a></li>
          <li>Health Canada product monograph (APO-cetirizine): <a href="https://pdf.hres.ca/dpd_pm/00076083.PDF" target="_blank">https://pdf.hres.ca/dpd_pm/00076083.PDF</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
